advair diskus

Generic: fluticasone propionate and salmeterol

Labeler: glaxosmithkline llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name advair diskus
Generic Name fluticasone propionate and salmeterol
Labeler glaxosmithkline llc
Dosage Form POWDER
Routes
RESPIRATORY (INHALATION)
Active Ingredients

fluticasone propionate 250 ug/1, salmeterol xinafoate 50 ug/1

Manufacturer
GlaxoSmithKline LLC

Identifiers & Regulatory

Product NDC 0173-0696
Product ID 0173-0696_c8c30de8-8d8e-4728-ae80-ae9a84b9b2ac
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021077
Listing Expiration 2026-12-31
Marketing Start 2001-02-05

Pharmacologic Class

Classes
adrenergic beta2-agonists [moa] corticosteroid hormone receptor agonists [moa] corticosteroid [epc] beta2-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01730696
Hyphenated Format 0173-0696

Supplemental Identifiers

RxCUI
896161 896165 896184 896185 896186 896190 896209 896212 896218 896222 896228 896229
UNII
6EW8Q962A5 O2GMZ0LF5W

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name advair diskus (source: ndc)
Generic Name fluticasone propionate and salmeterol (source: ndc)
Application Number NDA021077 (source: ndc)
Routes
RESPIRATORY (INHALATION)
source: ndc

Resolved Composition

Strengths
  • 250 ug/1
  • 50 ug/1
source: ndc
Packaging
  • 1 INHALER in 1 CARTON (0173-0696-00) / 60 POWDER in 1 INHALER
  • 1 INHALER in 1 CARTON (0173-0696-04) / 14 POWDER in 1 INHALER
source: ndc

Packages (2)

Ingredients (2)

fluticasone propionate (250 ug/1) salmeterol xinafoate (50 ug/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "c8c30de8-8d8e-4728-ae80-ae9a84b9b2ac", "openfda": {"unii": ["6EW8Q962A5", "O2GMZ0LF5W"], "rxcui": ["896161", "896165", "896184", "896185", "896186", "896190", "896209", "896212", "896218", "896222", "896228", "896229"], "spl_set_id": ["4eeb5f6a-593f-4a9e-9692-adefa2caf8fc"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INHALER in 1 CARTON (0173-0696-00)  / 60 POWDER in 1 INHALER", "package_ndc": "0173-0696-00", "marketing_start_date": "20010205"}, {"sample": false, "description": "1 INHALER in 1 CARTON (0173-0696-04)  / 14 POWDER in 1 INHALER", "package_ndc": "0173-0696-04", "marketing_start_date": "20010205"}], "brand_name": "ADVAIR DISKUS", "product_id": "0173-0696_c8c30de8-8d8e-4728-ae80-ae9a84b9b2ac", "dosage_form": "POWDER", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "0173-0696", "generic_name": "fluticasone propionate and salmeterol", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ADVAIR", "brand_name_suffix": "DISKUS", "active_ingredients": [{"name": "FLUTICASONE PROPIONATE", "strength": "250 ug/1"}, {"name": "SALMETEROL XINAFOATE", "strength": "50 ug/1"}], "application_number": "NDA021077", "marketing_category": "NDA", "marketing_start_date": "20010205", "listing_expiration_date": "20261231"}